CIK 0001790340
- Emerging growth company
Immuneering Corp
Sign in to watch- Ticker
- IMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-500-8080
- Business address
- 245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Accounting Officer acquired 4,458 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 400,000 shares at an average $2.90 ($1,160,181)
- 4 Open-market buy Director bought 2,900 shares at $2.55 ($7,385)
- 4 Open-market buy Director bought 25,000 shares at $2.55 ($63,713)
- 4 Open-market buy Chief Business Officer bought 3,900 shares at $2.57 ($10,015)
- 4 Open-market buy Chief Accounting Officer bought 1,500 shares at an average $2.67 ($4,009)
- 4 Open-market buy CHIEF PEOPLE OFFICER bought 3,818 shares at $2.88 ($10,993)
- 4 Open-market buy CHIEF SCIENTIFIC OFFICER bought 7,000 shares at $2.86 ($20,020)
Page 4 of 9 · 166 filings